Skip to content

Effect of different use strategies of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on perioperative hypotension and adverse cardiovascular events in older patients undergoing noncardiac surgery: a prospective, multicenter, randomized, double-blind, controlled trial

Effect of withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on perioperative hypotension and adverse cardiovascular events in elderly patients undergoing noncardiac surgery: a multicenter, randomized, double-blind, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039376
Enrollment
Unknown
Registered
2020-10-25
Start date
2020-11-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of ACEI/ARB in older patients undergoing noncardiac surgery

Interventions

Group ACEI/ARB continued:ACEI / ARB taken routinely in the morning of operation
Group ACEI/ARB withheld:ACEI / ARB withheld in the morning of operation

Sponsors

Department of Anesthesiology, the First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 60-80 years; 2. ASA II-III subjects who took ACEI or ARB drugs to treat hypertension for more than two weeks; 3. Patients scheduled for noncardiac surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Pregnant objects; 2. ACEI / ARB is used only at night, intermittently, or both; 3. Patients with uncontrollable hypertension (systolic blood pressure >= 180 mmHg or diastolic blood pressure >= 110 mmHg); 4. Patients with mean basal arterial pressure = B, creatinine >= 200 µ mol / L); 8. Patients who refused to participate.

Design outcomes

Primary

MeasureTime frame
perioperative hypotension events;

Secondary

MeasureTime frame
Duration of perioperative hypotension;Use of intravenous fluids and vasopressors;Postoperative hypotension events occurring in the surgical wards within 3 days after surgery;Perioperative neurocognitive disorders;Major adverse cardiocerebral events;Mortality within 30 days after surgery;

Countries

China

Contacts

Public ContactFuhai Ji

The First Affiliated Hospital of Suzhou University

253087615@qq.com+86 13656207331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026